Protein N-terminal processing: substrate specificity of Escherichia coli and human methionine aminopeptidases.

Methionine aminopeptidase (MetAP) catalyzes the hydrolytic cleavage of the N-terminal methionine from newly synthesized polypeptides. The extent of removal of methionyl from a protein is dictated by its N-terminal peptide sequence. Earlier studies revealed that MetAPs require amino acids containing small side chains (e.g., Gly, Ala, Ser, Cys, Pro, Thr, and Val) as the P1' residue, but their specificity at positions P2' and beyond remains incompletely defined. In this work, the substrate specificities of Escherichia coli MetAP1, human MetAP1, and human MetAP2 were systematically profiled by screening against a combinatorial peptide library and kinetic analysis of individually synthesized peptide substrates. Our results show that although all three enzymes require small residues at the P1' position, they have differential tolerance for Val and Thr at this position. The catalytic activity of human MetAP2 toward Met-Val peptides is consistently 2 orders of magnitude higher than that of MetAP1, suggesting that MetAP2 is responsible for processing proteins containing N-terminal Met-Val and Met-Thr sequences in vivo. At positions P2'-P5', all three MetAPs have broad specificity but are poorly active toward peptides containing a proline at the P2' position. In addition, the human MetAPs disfavor acidic residues at the P2'-P5' positions. The specificity data have allowed us to formulate a simple set of rules that can reliably predict the N-terminal processing of E. coli and human proteins.

[1]  Á. Furka,et al.  General method for rapid synthesis of multicomponent peptide mixtures. , 2009, International journal of peptide and protein research.

[2]  S. Chai,et al.  Discovery of inhibitors of Escherichia coli methionine aminopeptidase with the Fe(II)-form selectivity and antibacterial activity. , 2008, Journal of medicinal chemistry.

[3]  S. Davidsen,et al.  Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition. , 2008, Journal of proteome research.

[4]  T. Meinnel,et al.  Extent of N‐terminal modifications in cytosolic proteins from eukaryotes , 2008, Proteomics.

[5]  Jun O. Liu,et al.  Regulation of c-Src nonreceptor tyrosine kinase activity by bengamide A through inhibition of methionine aminopeptidases. , 2007, Chemistry & biology.

[6]  Thierry Meinnel,et al.  The Proteomics of N-terminal Methionine Cleavage*S , 2006, Molecular & Cellular Proteomics.

[7]  Jun O. Liu,et al.  Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression , 2006, Proceedings of the National Academy of Sciences.

[8]  A. Curnow,et al.  Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors , 2006, Proteins.

[9]  D. Pei,et al.  Traceless capping agent for peptide sequencing by partial edman degradation and mass spectrometry. , 2006, Analytical chemistry.

[10]  F. Nan,et al.  Metalloform-Selective Inhibition: Synthesis and Structure—Activity Analysis of Mn(II)-Form-Selective Inhibitors of Escherichia coli Methionine Aminopeptidase. , 2006 .

[11]  F. Nan,et al.  Metalloform-selective inhibition: synthesis and structure-activity analysis of Mn(II)-form-selective inhibitors of Escherichia coli methionine aminopeptidase. , 2005, Bioorganic & medicinal chemistry letters.

[12]  Jun O. Liu,et al.  Structural basis for the functional differences between type I and type II human methionine aminopeptidases. , 2005, Biochemistry.

[13]  M. Gu,et al.  Characterization of full length and truncated type I human methionine aminopeptidases expressed from Escherichia coli. , 2004, Biochemistry.

[14]  T. Meinnel,et al.  Protein N-terminal methionine excision , 2004, Cellular and Molecular Life Sciences CMLS.

[15]  F. Nan,et al.  Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. , 2003, Journal of medicinal chemistry.

[16]  D. Egan,et al.  Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese. , 2003, Biochemistry.

[17]  D. Pei,et al.  An improved method for rapid sequencing of support-bound peptides by partial edman degradation and mass spectrometry. , 2003, Journal of combinatorial chemistry.

[18]  K. Gevaert,et al.  Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides , 2003, Nature Biotechnology.

[19]  M. Doyle,et al.  Steady-state kinetic characterization of substrates and metal-ion specificities of the full-length and N-terminally truncated recombinant human methionine aminopeptidases (type 2). , 2001, Biochemistry.

[20]  H. Parekh,et al.  A Dde-based carboxy linker for solid-phase synthesis , 2001 .

[21]  M. F. White,et al.  High Resolution Structure of the Phosphohistidine-activated Form of Escherichia coli Cofactor-dependent Phosphoglycerate Mutase* , 2001, The Journal of Biological Chemistry.

[22]  K. Biemann,et al.  Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. , 1999, Chemistry & biology.

[23]  W. Bornmann,et al.  The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Biemann,et al.  Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. , 1997, Chemistry & biology.

[25]  X Li,et al.  Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  W. Zhou,et al.  A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. , 1994, Cancer research.

[27]  R A Bradshaw,et al.  Isolation and characterization of the methionine aminopeptidase from porcine liver responsible for the co-translational processing of proteins. , 1992, The Journal of biological chemistry.

[28]  D. Ingber,et al.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.

[29]  J. Smith,et al.  Purification and characterization of a methionine aminopeptidase from Saccharomyces cerevisiae. , 1990, The Journal of biological chemistry.

[30]  P. Dessen,et al.  Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Miller,et al.  pepM is an essential gene in Salmonella typhimurium , 1989, Journal of bacteriology.

[32]  S. Chang,et al.  Methionine aminopeptidase gene of Escherichia coli is essential for cell growth , 1989, Journal of bacteriology.

[33]  K. Myambo,et al.  Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure , 1987, Journal of bacteriology.

[34]  H. Bunn,et al.  Amino-terminal processing of proteins: hemoglobin South Florida, a variant with retention of initiator methionine and N alpha-acetylation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Stewart,et al.  Amino-terminal processing of mutant forms of yeast iso-1-cytochrome c. The specificities of methionine aminopeptidase and acetyltransferase. , 1985, The Journal of biological chemistry.

[36]  J. Waller,et al.  THE NH2-TERMINAL RESIDUES OF THE PROTEINS FROM CELL-FREE EXTRACTS OF E. COLI. , 1963, Journal of molecular biology.

[37]  R. Kaiser,et al.  Enhancement of cyanogen bromide cleavage yields for methionyl-serine and methionyl-threonine peptide bonds. , 1999, Analytical biochemistry.

[38]  K. Sudo,et al.  Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). , 1994, Anticancer research.

[39]  Y. Mechulam,et al.  Methionine as translation start signal: a review of the enzymes of the pathway in Escherichia coli. , 1993, Biochimie.

[40]  Kit S. Lam,et al.  A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.

[41]  G. von Heijne,et al.  Sequence determinants of cytosolic N-terminal protein processing. , 1986, European journal of biochemistry.